Published in:
Open Access 01-05-2011 | Erratum
Erratum to: A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
Published in: Journal of Neuro-Oncology | Issue 3/2011
Login to get accessExcerpt
The Abstract section of the original publication contains the following two errors:-
right column, lines 6–7: “...then every 3 weeks at 100 mg/m2...” should read “...then every 4 weeks at 80 mg/m2...”.
-
right column, lines 16–17: “Progression-free survival at 6 months was 61%.” should read “Progression-free survival at 6 months was 39%.”.